Efficacy and Safety of Tofacitinib in patients with severe active Rheumatoid Arthritis

Trial Profile

Efficacy and Safety of Tofacitinib in patients with severe active Rheumatoid Arthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Tofacitinib (Primary) ; Leflunomide; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Jun 2017 Results (n=28) evaluating the effects of tofacitinib on cardiovascular risk factors in rheumatoid arthritis patients during 12-month follow-up, presented at the 18th Annual Congress of the European League Against Rheumatism.
    • 17 Jun 2017 Pooled results the safety and efficacy of Tofacitinib in patients from this this and one another study (n=142), presented at the 18th Annual Congress of the European League Against Rheumatism
    • 02 Sep 2016 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top